1 Cannabis Stock I’m Buying While It’s Still Cheap

You’ll think I’m crazy, but with markets at lows not seen in years, perhaps the craziness of the market place is getting to me. I’ve been looking hard for cheap stocks to buy up while I can. Whereas before I would have to have a couple thousand dollars stashed away, right now I might need only a couple hundred bucks…

Read More

Now Is the Time to Bet on Pot Stocks

Pot stocks were hammered in 2019. Nearly every company lost at least 50% of its value. Cannabis demand, on the other hand, continues to climb. This disconnect provides patient investors a clear path to profit. As with any early-stage market, investors scrambled at the chance to inject pent-up capital into cannabis companies. In 2018, many pot stocks rose by more…

Read More

If You’re Going to Buy Weed, Buy It in Aggregate

If you haven’t noticed, Canadian cannabis producers are risky to own. The same volatility that allowed these companies to double on a weekly basis has allowed some of the same names to halve a weekly basis. Here’s my take on why investors looking to invest in cannabis ought to buy the Exchange-Traded Fund (ETF) tracking the sector: the Horizons Marijuana…

Read More

This Is the Most Important Driver for Cannabis Investors!

For cannabis investors who continue to hold positions in any of Canada’s cannabis producers, every news cycle seems to bring unwanted negative news, driving volatility in the sector and valuations lower, as many take money off the table after a wild ride that has seen valuations reach astronomical levels. Determining what precisely has driven this volatility and scared many investors…

Read More

Aurora Cannabis (TSX:ACB) Revenue Falls 26%: Time to Sell the Stock?

This past week, Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) released its earnings for the second quarter of 2020, and they were, predictably, bad. The company reported a 26% drop in net revenue along with a colossal $1.3 billion GAAP net loss. While the net loss was mostly due to a goodwill impairment charge, the company also reported a $80 million adjusted EBITDA loss that…

Read More

Top Pot Stocks for the Next Generation of Cannabis Products

It’s time for a new chapter in pot investing. In 2018, cannabis stocks soared as the market rushed to take advantage. Last year, the tides turned, as valuations came down from nosebleed levels. In 2020, the story will evolve again, even if few investors are prepared. The biggest shift will be a newfound appreciation for novel cannabis form factors. In…

Read More

Marijuana Investors: 2 Powerful Trends to Track in 2020

The marijuana boom was supposed to happen last year. Investors expected the likes of Canopy Growth, Aphria, and Aurora Cannabis (TSX:ACB)(NYSE:ACB) to reach stratospheric heights in prosperity. Instead, the legal marijuana sector faced an enormously challenging year. Canadian investors saw both big and small names in the industry struggle. The three major cannabis producers tanked to devastating lows after climbing to…

Read More

Why Canopy Growth (TSX:WEED) Stock Can Get Back All-Time Highs in 2020

The second phase of cannabis legalization in Canada, often called “Cannabis 2.0,” has reinvigorated many stocks in the sector over the last few months. Cannabis ETFs have gained momentum after being pummeled for most of 2019. Horizons Marijuana Life Sciences ETF has increased 7.6% over the past month as of close on January 16. Canopy Growth remains the biggest Canadian cannabis player. Shares…

Read More

Canopy Growth (TSX:WEED) Stock Price: Should You Buy the Bounce?

Marijuana stocks have picked up a new tailwind in recent days, and investors are wondering if this could be the start of another big rally for share prices of the cannabis producers. Cannabis 2.0 Canopy Growth (TSX:WEED)(NYSE:CGC) is a leader in the Canadian and global marijuana industry. The stock has traded as high as $70 per share in the past…

Read More

This $520-Million Pot Stock Is Now Too Cheap to Ignore

Demand for legal pot continues to climb to new heights. Investment bank Cowen Inc has raised its 2030 sales forecast from $75 billion to $80 billion, only to bump it again to $85 billion last November. Globally, several analysts are now expecting sales to peak above $200 billion. If adjacent markets are any indication, even these rosy estimates could prove…

Read More